Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract ...

SPEAR proposal reflects current evidence on monoclonal antibodies in treatment for Long COVID and identifies VYD2311 as a promising ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

The Study Design and Data Analysis support group at USF’s College of Public Health (COPH), that’s who. Known as the SDDA, the ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...

HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / / Medicus Pharma Ltd. ...

Written agreement from FDA for single-arm, open-label, baseline-controlled registrational trial evaluating composite primary endpoint of improvement in CGI-I and gain of developmental milestone/skill ...